List of Studies ( Metabolite:CAR 19:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004321 | AN007200 | Food intake-independent metabolic alterations in cachectic C26 mice compared to non-cachectic C26 mice | Blood | Mouse | Cancer | Harvard School of Public Health | LC-MS |
| ST004229 | AN007039 | Aromatic Microbial Metabolite Hippuric Acid Potentiates Pro-Inflammatory Responses in Macrophages through TLR-MyD88 Signaling and Lipid Remodeling - Lipidomics analysis on bone marrow derived macrophages pre-treated with hippuric acid and stimulated with M1-like (LPS+IFNγ) | Macrophages | Mouse | Bacterial infection | The Wistar Institute | LC-MS |
| ST004039 | AN006677 | Soma to neuron communication links stress adaptation to stress avoidance behavior | Worms | C. elegans | Stress | University of Pittsburgh | LC-MS |
| ST003637 | AN005973 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003528 | AN005795 | Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma | Liver | Mouse | Cancer | University of Utah | LC-MS |
| ST003326 | AN005449 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003275 | AN005362 | Lipidomics analysis within healthy donors and end-stage heart failure with a focus on ischaemic cardiomyopathy with diabetes | Heart | Human | Heart disease | University of Sydney | LC-MS |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003242 | AN005311 | Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. | Kidney | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Stress | University of Rochester Medical Center | LC-MS |
| ST003239 | AN005305 | Lipidomic analysis of adipose from Gclc WT and whole-body Gclc KO mice. | Adipose tissue | Mouse | Oxidative stress | University of Rochester Medical Center | LC-MS |
| ST003168 | AN005198 | Lipidomic analysis of cryopreserved human cardiac tissue from young and ageing adults | Heart | Human | Heart disease | University of Sydney | LC-MS |
| ST003038 | AN004984 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Liver | Mouse | Diabetes | Vanderbilt University Medical Center | LC-MS |
| ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST001950 | AN003174 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | LC-MS |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000999 | AN001628 | Natural genetic variation in C. elegans identified genomic loci controlling metabolite levels | Worms | C. elegans | Academic Medical Center of Amsterdam | LC-MS |
